Status:
TERMINATED
BFR Therapy in Patients With Rotator Cuff Tears
Lead Sponsor:
Henry Ford Health System
Conditions:
Blood Flow Restriction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to examine the effect of utilizing blood flow restriction (BFR) therapy in patients treated both non operatively and operatively for rotator cuff tears (RCT). BFR has been...
Detailed Description
Patients who are seen in clinic for rotator cuff pathology will undergo treatment for their rotator cuff based on a shared-decision making process with the orthopedic surgeon, irrespective of this stu...
Eligibility Criteria
Inclusion
- patients aged 18-80 who suffered a rotator cuff tear
- Patients undergoing arthroscopic rotator cuff repair
- Patients undergoing nonoperative treatment with physical therapy
Exclusion
- Subjects will be excluded if they are undergoing revision rotator cuff repair, history of DVT, neurovascular injury, unable to tolerate BFR treatment, unable to complete physical therapy, peripheral vascular disease
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04384120
Start Date
June 1 2020
End Date
July 1 2022
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health Systems
Detroit, Michigan, United States, 48202